Advertisement

C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

US WorldMeds and Adamis Pharmaceuticals Announce U.S. Launch of ZIMHI™ Naloxone Product

Thursday, March 31, 2022

USWM LLC and Adamis Pharmaceuticals Corporation today announced the US launch and availability of ZIMHI naloxone HCL Injection USP mg mL ZIMHI is a highdose naloxone injection product FDAapproved for use in the treatment of opioid overdose as emerge...

Jaguar Health Enters Exclusive Crofelemer Distribution and License Agreement with Quadri Pharmaceuticals Store for Multiple Target Indications in Middle East Markets

Thursday, March 31, 2022

Jaguar Health Inc announced that the company has entered an agreement the Agreement with Quadri Pharmaceuticals Store LLC Quadri Pharma that grants Quadri Pharma exclusive promotional commercialization and distribution rights for specified human indi...

Eisai Announces Acquisition of Arteryex Shares (Making Arteryex a Subsidiary) to Strengthen and Rapidly Expand the Foundation of its Digital Solution Business

Thursday, March 31, 2022

Eisai Co Ltd announced today that Eisai has acquired a majority of the shares issued by Arteryex Inc Headquarters Tokyo CEO Li Dongying Arteryex a company that plans and develops software related to digital solutions such as provision of medical info...

Distribution agreement signed with Vector Pharma for Alkindi®

Wednesday, March 30, 2022

Diurnal Group plc AIM DNL the specialty pharmaceutical company targeting patient needs in chronic endocrine hormonal diseases announces a distribution agreement with Vector Pharma FCZO Vector Pharma a leading fullservice distributor for the distribut...

Universe Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health to Develop its Digital Marketing and Sales on E-Commerce Platforms

Wednesday, March 30, 2022

Universe Pharmaceuticals INC a pharmaceutical producer and distributor in China today announced that the Company had entered into a strategic cooperation agreement the Agreement with LianOu Health Pharmaceutical Guangzhou Co Ltd LianOu Health a hight...

Collegium Announces Master Settlement Agreement Resolving Pending Opioid-Related Litigation

Wednesday, March 30, 2022

Collegium Pharmaceutical Inc announced the execution of a Master Settlement Agreement resolving all pending opioidrelated lawsuits brought against the Company by cities counties and other subdivisions in the United States on March The execution of...

Teva Reaches Agreement With Florida to Settle the State’s Opioid-Related Claims

Wednesday, March 30, 2022

Teva Pharmaceuticals a US affiliate of Teva Pharmaceutical Industries Ltd and its affiliates has reached an agreement with the Attorney General of Florida that settles the states and its subdivisions opioidrelated claims The settlement will provide F...

Brii Bio Announces Strategic Partnership with Sinopharm to Advance Commercialization of Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China

Wednesday, March 30, 2022

Brii Biosciences Limited Brii Bio or the Company stock code HK a multinational company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens today announced that TSB Therapeutics Beijing Co...

Vyant Bio and OrganoTherapeutics Announce Strategic Collaboration to Discover Therapeutics to Treat Parkinson’s Disease

Tuesday, March 29, 2022

Vyant Bio Inc an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders and OrganoTherapeutics a developer of proprietary patientspecific organoids that recapitulate Parkinsons Disea...

Boehringer Ingelheim selects Veeva Development Cloud worldwide to bring innovative therapies to patients faster

Tuesday, March 29, 2022

Boehringer Ingelheim and Veeva Systems announce Boehringer Ingelheims selection of Veeva Development Cloud to drive endtoend processes and seamless information sharing enterprise wide for greater speed in the delivery of innovative therapies Boehring...